Neurimmune AG Employee Directory

Pharmaceutical ManufacturingZurich, Switzerland51-200 Employees

Neurimmune is a biopharmaceutical company translating human immune memory into antibody therapeutics. Neurimmune discovered aducanumab for Alzheimer's disease together with a team of researchers at the University of Zurich and licensed it to Biogen.
 
Neurimmune's Reverse Translational Medicine technology platform translates the genetic information from human white blood cells into selective high-affinity antibody drug candidates. Besides aducanumab, Neurimmune discovered cinpanemab for Parkinson's disease, the anti-tau antibody BIIB076 for Alzheimer's disease, the anti-miSOD1 antibody AP-101 for amyotrophic lateral sclerosis, and the anti-ATTR antibody NI006 for cardiomyopathy. These programs are currently evaluated in clinical trials.

Find Neurimmune AG employees' phone numbers or email addresses

Neurimmune AG Global Highlights

Europe
76

Switzerland
75
Netherlands
1

Oceania
1

Australia
1

Neurimmune AG's Leadership

C. H.
Chief Medical Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. B.
Chief Business Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. G.
Chief Scientific Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. G.
Head Of Information Technology
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. W.
Head Of Administration
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. N.
Ceo & President
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. S.
Group CFO
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. S.
Coo
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Contact profiles from Neurimmune AG

Name

Title

Contact Info

Location

Last Update

C. H.
Chief Medical Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
SwitzerlandZurich
May 05, 2024
D. S.
Group CFO
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
SwitzerlandZurich
May 05, 2024
F. B.
Chief Business Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
SwitzerlandZurich
Oct 24, 2024
J. G.
Chief Scientific Officer
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
SwitzerlandZurich
Nov 12, 2024
M. S.
Coo
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Feb 15, 2024
R. N.
Ceo & President
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Switzerland
Nov 14, 2024
S. M.
Vp Research & Technology
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
SwitzerlandZurich
Oct 30, 2024
B. C.
Principal Scientist, Head Of Antibody Discovery And Automation
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
SwitzerlandZurich
Nov 15, 2024
K. G.
Head Of Information Technology
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
SwitzerlandZurich
Oct 23, 2024
A. W.
Head Of Administration
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Neurimmune AG and Millions of Other Companies
Sign up for full access to Neurimmune AG information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
SwitzerlandZurich
Oct 18, 2023

Frequently Asked Questions

What is Neurimmune AG known for?

Neurimmune AG was founded in 2006 operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in Wagistrasse 13 Schlieren, Zurich 8952 CH; you can contact the main corporate office by phone at

+41-414475****

. Explore Neurimmune AG's company overview page for more information.

What is Neurimmune AG's most common email format?

Neurimmune AG employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Neurimmune AG email formats with LeadIQ.

How many employees does Neurimmune AG have currently?

Neurimmune AG has approximately 70 employees as of November 2024. These team members are located across 2 continents, including EuropeOceania.

Who are Neurimmune AG's key employees and leadership?

As of November 2024, Neurimmune AG's key employees include:

Chief Medical Officer: C. H.
Chief Business Officer: F. B.
Chief Scientific Officer: J. G.
Head Of Information Technology: K. G.
Head Of Administration: A. W.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking